HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A clinical multivariate study on bone change after parathyroidectomy in patients with renal osteodystrophy].

Abstract
This study investigated the changes of bone lesions after parathyroidectomy (PTX) in patients with renal osteodystrophy. Fifty-eight patients (mean age 43.7 +/- 8.4 years and mean duration of hemodialysis 120.9 +/- 32.1 months), who were resistant to medical treatments, were studied. Total PTX was followed by massive administration of alfacalcidol on these patients. The clinical symptoms, hematological findings, radiographic findings and second metacarpal bone density during the first 2 years following PTX were studied. After the operation, the clinical symptoms, hematological findings as well as radiographic findings improved in all of the patients and the density of the second metacarpal bone increased in 37 out of 40 patients. From these results we concluded that total PTX followed by massive administration of active vitamin D was effective in improving bone lesions and bone mineral density on patients with renal osteodystrophy.
AuthorsM Denda, K Kushida
JournalNihon Seikeigeka Gakkai zasshi (Nihon Seikeigeka Gakkai Zasshi) Vol. 67 Issue 1 Pg. 12-21 (Jan 1993) ISSN: 0021-5325 [Print] Japan
PMID8454922 (Publication Type: Journal Article)
Chemical References
  • Hydroxycholecalciferols
  • alfacalcidol
Topics
  • Adult
  • Bone Density
  • Bone and Bones (diagnostic imaging)
  • Chronic Kidney Disease-Mineral and Bone Disorder (drug therapy, physiopathology, surgery)
  • Female
  • Humans
  • Hydroxycholecalciferols (therapeutic use)
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Parathyroidectomy
  • Postoperative Period
  • Radiography

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: